{"id":146,"date":"2018-11-12T20:06:38","date_gmt":"2018-11-12T20:06:38","guid":{"rendered":"https:\/\/bridgebioprod.wpengine.com\/?p=146"},"modified":"2024-10-02T13:20:29","modified_gmt":"2024-10-02T17:20:29","slug":"bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/","title":{"rendered":"BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children\u2019s to Accelerate Development of Genetic Disease Therapeutics"},"content":{"rendered":"\r\n<p>PALO ALTO, Calif.\u00a0and\u00a0CINCINNATI,\u00a0Nov. 12, 2018\u00a0\/PRNewswire\/ &#8212;\u00a0<a href=\"http:\/\/bridgebio.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">BridgeBio Pharma LLC<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.cincinnatichildrens.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Cincinnati Children&#8217;s Hospital Medical Center<\/a>\u00a0today announced they are entering into a research collaboration to identify and develop genetic disease therapies. This partnership will combine BridgeBio&#8217;s strengths in therapeutic development for diseases of high unmet need with Cincinnati Children&#8217;s world-class researchers and clinicians. As a global research center of excellence, Cincinnati Children&#8217;s represents an ideal partner for BridgeBio and reinforces BridgeBio&#8217;s commitment to collaborating with leading researchers toward the mutual goal of discovering new therapies targeting genetic diseases at the source.<\/p>\r\n\r\n\r\n\r\n<p>&#8220;BridgeBio is privileged to partner with leading experts at Cincinnati Children&#8217;s, an institution whose impact on science and patients we admire. We hope we can help advance the mission by partnering to move therapies forward to patients,&#8221; said\u00a0Neil Kumar, co-founder and CEO of BridgeBio.<\/p>\r\n\r\n\r\n\r\n<p>&#8220;We are excited to launch this new alliance with BridgeBio to bring new and innovative therapies to some of the most vulnerable patients impacted by rare and complex genetic diseases,&#8221; said\u00a0Margaret Hostetter, MD, Chief Medical Officer of Cincinnati Children&#8217;s and Director, Cincinnati Children&#8217;s Research Foundation.<\/p>\r\n\r\n\r\n\r\n<p>&#8220;This collaboration exemplifies Cincinnati Children&#8217;s commitment to accelerating discoveries towards commercialization through win-win academic-industry partnerships,&#8221; added\u00a0Mike Pistone, Director of Acceleration for Cincinnati Children&#8217;s Innovation Ventures, the group managing this program.<\/p>\r\n\r\n\r\n\r\n<p>Under the terms of the agreement, BridgeBio will have the opportunity to sponsor and collaboratively develop selected research programs. The agreement represents a flexible model that facilitates accelerated genetic disease research.<\/p>\r\n\r\n\r\n\r\n<p><strong>About BridgeBio Pharma<\/strong><\/p>\r\n\r\n\r\n\r\n<p>BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients with unmet needs. Founded in 2015 by a team of industry veterans, the company has built a robust portfolio of 19 transformative drugs ranging from pre-clinical to late stage development in multiple therapeutic areas including oncology, cardiology, dermatology, and endocrinology. The company&#8217;s focus on scientific excellence and rapid execution aims to translate today&#8217;s discoveries into tomorrow&#8217;s medicines. For additional information, visit\u00a0<a href=\"http:\/\/bridgebio.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">BridgeBio.com<\/a>.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif.\u00a0and\u00a0CINCINNATI,\u00a0Nov. 12, 2018\u00a0\/PRNewswire\/ &#8212;\u00a0BridgeBio Pharma LLC\u00a0and\u00a0Cincinnati Children&#8217;s Hospital Medical Center\u00a0today announced they are entering into a research collaboration to identify and develop genetic disease therapies. This partnership will combine BridgeBio&#8217;s strengths in therapeutic development for diseases of high unmet need with Cincinnati Children&#8217;s world-class researchers and clinicians. As a global research center of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-146","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":{"meta_short_title":"BridgeBio to Develop Genetic Disease Therapeutics","meta_description":"BridgeBio Pharma and Cincinnati Children's Hospital Medical Center announced a research collaboration to identify and develop genetic disease therapies.","meta_share_image":false,"external_link":"","external_link_source":"","presentation":"","people":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cincinnati Children\u2019s Hospital Collaboration With BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cincinnati Children\u2019s Hospital Collaboration With BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-12T20:06:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-02T17:20:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Julianne Twining\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Julianne Twining\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/\",\"name\":\"Cincinnati Children\u2019s Hospital Collaboration With BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2018-11-12T20:06:38+00:00\",\"dateModified\":\"2024-10-02T17:20:29+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/f567122d9069e4cac0b57561cb43f962\"},\"description\":\"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children\u2019s to Accelerate Development of Genetic Disease Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/f567122d9069e4cac0b57561cb43f962\",\"name\":\"Julianne Twining\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/925ac813b5977675ca06cc772ee2d3fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/925ac813b5977675ca06cc772ee2d3fe?s=96&d=mm&r=g\",\"caption\":\"Julianne Twining\"},\"url\":\"https:\/\/bridgebio.com\/author\/julianne\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cincinnati Children\u2019s Hospital Collaboration With BridgeBio","description":"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Cincinnati Children\u2019s Hospital Collaboration With BridgeBio","og_description":"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/","og_site_name":"BridgeBio","article_published_time":"2018-11-12T20:06:38+00:00","article_modified_time":"2024-10-02T17:20:29+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Julianne Twining","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Julianne Twining","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/","name":"Cincinnati Children\u2019s Hospital Collaboration With BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2018-11-12T20:06:38+00:00","dateModified":"2024-10-02T17:20:29+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/f567122d9069e4cac0b57561cb43f962"},"description":"BridgeBio and Cincinnati Children\u2019s Hospital Medical Center announced their research collaboration to identify and develop genetic disease therapies.","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children\u2019s to Accelerate Development of Genetic Disease Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/f567122d9069e4cac0b57561cb43f962","name":"Julianne Twining","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/925ac813b5977675ca06cc772ee2d3fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/925ac813b5977675ca06cc772ee2d3fe?s=96&d=mm&r=g","caption":"Julianne Twining"},"url":"https:\/\/bridgebio.com\/author\/julianne\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/146"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=146"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/146\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}